Illumina (ILMN) Gains from Investment Securities (2012 - 2026)
Illumina's (ILMN) quarterly Gains from Investment Securities came in at -$16.0 million in Q2 2026, up 23.81% on a YoY basis from -$12.9 million in Q2 2025, and little changed quarter-over-quarter from -$16.0 million in Q1 2026.
Analysis
Illumina (ILMN) Gains from Investment Securities (2012 - 2026) Analysis & Trends
Illumina (ILMN) has reported Gains from Investment Securities for 11 consecutive years, with -$16.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gains from Investment Securities rose 23.81% year-over-year to -$16.0 million; the trailing twelve-month figure through Jun 2026 stood at -$18.0 million (up 80.43% YoY), and the FY2025 full-year result was -$18.0 million, up 94.29% from the prior year.
- Gains from Investment Securities steadied at -$16.0 million in Q2 2026 per ILMN's latest filing, from -$16.0 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $58.0 million in Q4 2023 and bottomed at -$271.0 million in Q2 2024.
- Historically, Gains from Investment Securities has averaged -$27.1 million across 5 years, with a median of -$11.0 million in 2024.
- The widest YoY moves for Gains from Investment Securities: up 1700.0% in 2024, down 1034.48% in 2024.
- Over 5 years, Gains from Investment Securities stood at -$49.0 million in 2022, then jumped by 218.37% to $58.0 million in 2023, then plunged by 118.97% to -$11.0 million in 2024, then jumped by 200.0% to $11.0 million in 2025, then slumped by 245.45% to -$16.0 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$16.0 million, -$16.0 million, and $11.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -16.00 Mn |
| Mar 29, 2026 | -16.00 Mn |
| Dec 28, 2025 | 11.00 Mn |
| Sep 28, 2025 | 3.00 Mn |
| Jun 29, 2025 | -21.00 Mn |
| Mar 30, 2025 | -11.00 Mn |
| Dec 29, 2024 | -11.00 Mn |
| Sep 29, 2024 | -49.00 Mn |
| Jun 30, 2024 | -271.00 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 58.00 Mn |
| Oct 1, 2023 | -110.00 Mn |
| Jul 2, 2023 | 29.00 Mn |
| Apr 2, 2023 | -1.00 Mn |
| Apr 3, 2022 | -49.00 Mn |
| Jan 2, 2022 | 5.00 Mn |
| Oct 3, 2021 | 8.00 Mn |
| Jan 3, 2016 | 325,000.00 |
| Sep 27, 2015 | 1.11 Mn |
| Jun 28, 2015 | 2.33 Mn |